Exclusion criteria included patients with type 1 DM, chronic kidney disease, congestive heart failure, recent ischemic attacks, hepatic cell failure, SGLT2 (Sodium-glucose Cotransporter-2) inhibitors users and pregnant females. The gene discussed is SLC5A2; the disease is chronic kidney disease.